Doxycycline, a broad-spectrum bacteriostatic antibiotic, is in short supply, according to the American Society of Health-System Pharmacists.
 
Doxycycline manufacturers attribute the drug shortage to scarce raw materials and to supply and demand, although not all manufacturers could provide reasons for the shortage, the ASHP Drug Shortages Resource Center reported. 
 
A bulletin on the ASHP website details information about the shortage, including a list describing the affected doxycycline products, implications for patients and potential substitutes. To review the bulletin, visit ASHP online.